Advertisement
For adolescents with generalized anxiety disorder

Escitalopram Reduces Symptoms of Anxiety in Teens With GAD

0
Increasing CYP2C19 metabolism linked to reductions in escitalopram Cmax, AUC
Internationally

About One in Three Multiple Sclerosis Patients Have Migraine

0
Pooled prevalence of migraine 31 percent in MS patients, with significant variance internationally
About half of waivered clinicians prescribe buprenorphine for opioid use disorder and most treat at levels below their patient limits

About Half of Waivered Clinicians Prescribe Buprenorphine for OUD

0
Percentages much higher for actively prescribing U.S. clinicians with 275 and 100 versus 30 patients
An electronic alert may reduce excessive prescribing of short-acting beta2 agonists among patients with asthma in primary care

Electronic Alert May Cut Excessive SABA Prescribing in Asthma

0
Repeat SABA prescribing for patients with asthma decreased in the 12 months following the alert
Vitamin D3 supplementation does not prolong the time to severe asthma exacerbation among children with persistent asthma and low vitamin D levels

Vitamin D Supplement No Benefit in Pediatric Persistent Asthma

0
No improvement seen compared with placebo in children with asthma and low vitamin D levels
A school-located influenza vaccination intervention is associated with a reduction in the incidence of influenza hospitalization

School-Located Influenza Vaccine Intervention Beneficial

0
SLIV intervention linked to drop in incidence of influenza hospitalization in school-aged children, adults
Nine individual antihypertensive agents from the classes of angiotensin agents

Antihypertensive Agents Not Tied to Higher Risk for Depression

0
Depression rates down with nine antihypertensive agents, including enalapril, amlodipine, atenolol
Renin-angiotensin-aldosterone system inhibitors are beneficial for hypertensive patients with COVID-19

RAAS Inhibitors May Benefit HTN Patients With COVID-19

0
Risk for death, death/critical outcomes lower with use of RAAS inhibitors for hypertension
Patients with moderate COVID-19 receiving a five-day course of remdesivir have a statistically significant difference in clinical status compared with usual care

Clinical Impact of Remdesivir in Moderate COVID-19 Unclear

0
Significant difference seen in clinical status versus usual care for five-day, but not 10-day, course
For patients undergoing common orthopedic sports procedures

Nonopioid Pain Protocol Feasible After Sports Orthopedic Surgery

0
45 percent of patients did not require opioids for management of postoperative pain